Bradley Mark J. Eli Lilly & CO Transaction History

Bradley Mark J.

$99.3 Million
Q2 2023

A detailed history of Bradley Mark J. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bradley Mark J. holds 11,965 shares of LLY stock, worth $9.37 Million. This represents 5.65% of its overall portfolio holdings.

Number of Shares

11,965

Previous 19,040 37.16%

Holding current value

$9.37 Million

Previous $6.54 Million 14.18%

% of portfolio

5.65%

Previous 4.74%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $2.48 Million - $3.32 Million	-7,075 Reduced 37.16%	11,965 $5.61 Million
Q1 2023 Jun 09, 2023	BUY	$310.63 - $364.82 $18,637 - $21,889	60 Added 0.32%	19,040 $6.54 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $427,116 - $501,627	1,375 Added 7.81%	18,980 $6.52 Million
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $64,310 - $74,934	-200 Reduced 1.12%	17,605 $6.44 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $2,964 - $3,378	-10 Reduced 0.06%	17,805 $5.76 Million
Q2 2022 Jul 15, 2022	SELL	$278.73 - $327.27 $163,057 - $191,452	-585 Reduced 3.18%	17,815 $5.78 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $86,835 - $107,914	-370 Reduced 1.97%	18,400 $5.27 Million
Q4 2021 Mar 07, 2022	SELL	$224.85 - $279.04 $150,649 - $186,956	-670 Reduced 3.45%	18,770 $5.19 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $582,808 - $717,227	-2,630 Reduced 11.92%	19,440 $4.49 Million
Q2 2021 Jul 22, 2021	SELL	$180.55 - $233.54 $603,939 - $781,191	-3,345 Reduced 13.16%	22,070 $5.07 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $204,578 - $264,836	-1,245 Reduced 4.67%	25,415 $4.75 Million
Q4 2020 Feb 18, 2021	BUY	$130.46 - $172.63 $3.48 Million - $4.6 Million	26,660 New	26,660 $4.5 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Mark J., based on Form 13F filings with the SEC.

News

Stay updated on Bradley Mark J. with notifications on news.

Account